Largest Teen Weed Study Drops Bombshell

Nearly half a million teenagers were tracked for years, and what researchers found should make every parent of a pot-curious kid put down their coffee and pay close attention.

Quick Take

A Kaiser Permanente study of 463,396 teens found cannabis use more than doubled the risk of psychotic and bipolar disorders by young adulthood.
Cannabis use showed up an average of 1.7 to 2.3 years before psychiatric diagnoses, suggesting the drug came first, not the mental illness.
Even occasional use, not just daily or heavy use, was enough to trigger the elevated risk.
The younger a teen starts using cannabis, the higher the risk, pointing to a clear age-of-exposure effect.

The Biggest Teen Cannabis Study Ever Just Dropped a Bombshell

In February 2026, researchers at Kaiser Permanente published results from the largest study of its kind in JAMA Health Forum. They followed 463,396 teenagers, ages 13 to 17, through age 26. Every teen in the study was screened for cannabis use during routine pediatric checkups between 2016 and 2023. The result: teens who reported using cannabis were more than twice as likely to later be diagnosed with a psychotic disorder or bipolar disorder compared to teens who did not use it.^[1]

The numbers behind those diagnoses are sobering. During the follow-up period, researchers recorded more than 4,000 new diagnoses of psychotic and bipolar disorders, more than 62,000 new diagnoses of depression, and more than 73,000 new diagnoses of anxiety disorders.^[8] Cannabis users also faced a 34% higher risk of depression and a 24% higher risk of anxiety. These are not small signals buried in noisy data. These are large, consistent patterns across hundreds of thousands of kids.

The Timing Detail That Changes Everything

Critics of cannabis-mental health research always reach for the same escape hatch: maybe troubled teens just self-medicate with weed. That argument has less room to breathe here. Cannabis use showed up in health records an average of 1.7 to 2.3 years before any psychiatric diagnosis was made.^[3] The researchers also excluded teens who already had mental health symptoms at the start of the study. The drug came first. The diagnosis came later. That sequence matters enormously when debating cause versus coincidence.

The study also held up after researchers adjusted for other substance use, prior psychiatric history, and socioeconomic factors.^[1] The doubled risk for psychosis and bipolar disorder did not shrink away when those variables were removed from the equation. That kind of statistical durability is exactly what separates a strong study from a flimsy one, and this study is strong.

You Do Not Have to Be a Heavy User for the Risk to Apply

Here is the detail most parents miss entirely. The study did not measure daily use or cannabis addiction. It measured past-year use, meaning any use at all in the prior twelve months.^[3] Occasional weekend use, a few times at a party, trying it once or twice with friends. All of it was enough to show the same doubled risk for psychotic and bipolar disorders. The threshold for harm appears to be far lower than the culture currently assumes, especially among teens who believe casual use is basically harmless.

Teen Psychosis Spike Tied to Illegal Spice-Laced Vapes Sold to Kids.

A significant rise in teenage psychosis is being linked to vapes containing spice, a synthetic that mimics that effects of cannabis, prompting calls for further research and stricter enforcement in schools.… pic.twitter.com/IYN9ePnqCc

— The National Pulse (@TheNatPulse) June 27, 2026

The Centers for Disease Control and Prevention (CDC) has separately noted that in 2022, nearly 31% of 12th graders reported using cannabis in the past year.^[12] Cross that statistic with the Kaiser Permanente findings and the math becomes alarming. A generation of teenagers is moving through a period of peak brain development while routinely using a substance now linked, in the largest study ever conducted on the question, to dramatically elevated psychiatric risk.

What the Study Cannot Prove, and Why That Is Not a Get-Out-of-Jail Card

The researchers themselves acknowledged the study cannot definitively prove cannabis causes mental illness.^[10] Unmeasured factors like genetics and childhood trauma could still be influencing outcomes. The data relied on self-reported use, not lab-confirmed testing, which introduces some recall error. And the Kaiser Permanente patient population may not perfectly mirror all American teenagers. These are real limitations. They deserve honest acknowledgment.

But here is the problem with leaning too hard on those caveats. The cannabis industry and its media allies routinely use “correlation is not causation” as a rhetorical off-ramp, not a scientific argument. The 1.7 to 2.3 year gap between use and diagnosis, the consistent results after controlling for confounders, and the finding that even occasional users faced doubled risk are not the fingerprints of a weak study. They are the fingerprints of a serious public health signal that deserves serious public health action, not corporate spin.^[5]

38 States Have Legalized Weed While This Data Was Being Collected

As of 2026, 38 states have legalized recreational cannabis, and cannabis marketing increasingly reaches young adults. Public health messaging aimed at teenagers has not kept pace. The American Psychiatric Association and the National Institute of Mental Health have not issued formal statements on these findings. That institutional silence, while a massive study sits in plain view, is a failure worth naming. The teenage brain is not ready for cannabis, and the policy environment is not protecting it.^[4]